AFT Pharmaceuticals Health Care
Pharmaceuticals

$3.400 (0%)

High -	Low -	Trades -	Turnover $0	Volume 0
15 September 2026 at 4:03pm

Market Cap (14-Sep) $359,166,912 (480th)	Close (30-Jun) $3.40 0 (0%)	Volume (30-Jun) 0	Shortsold (6-Aug) 667 (0.00%) (670th)
52w High $4.13	52w Low $2.29	P/E 18.18	EPS 0.11

Short Interest

ASIC data, 6 Aug 2021

% Shorted

0.00%

vs 0.00% prior report

Most Shorted Rank

670th

of 689 shorted ASX stocks

Peak Short

0.02%

Nov 2020

Days to Cover

0.3

at 50d avg vol

View full short position history →

	Subject
	AFP AFP Ann: change of capital notice
	1 (current) 2 3
	AFP AFP Ann: Application for quotation of securities - AFP
	AFP AFP Ann: Officers interest
	AFP AFP Ann: capital change notice
	AFP AFP Ann: AFP to announce full year results on Monday May 23 2022
	AFP AFP Ann: Application for quotation of securities - AFP
	AFP AFP Ann: Capital Change Notice
	AFP AFP Ann: AFT prevails in comparative advertising judgement
	AFP AFP Ann: AFT notes FDA approval for Pascomer alternative
	AFP AFP Ann: FFC: Farmaforce and AFT Pharmaceuticals Partnership
	AFP AFP Ann: Disclosure of Directors & Senior Managers Relevant Interests
	AFP AFP Ann: 2022 New Year letter to investors
	AFP AFP Ann: Disclosure of Directors and Senior Managers Relevant Interes
	AFP AFP Ann: Application for quotation of securities - AFP
	AFP AFP Ann: AFT welcomes Australian Federal Court appeal success
	AFP AFP Ann: amended capital notice
	AFP AFP Ann: Application for quotation of securities - AFP
	AFP AFP Ann: capital change notice
	AFP AFP Ann: Presentation Slide 16 Correction
	AFP AFP Ann: 211118 AFT Interim Announcement FY2022 App2
	AFP AFP Ann: 211118 AFT Interim Financial Statements FY22
	AFP AFP Ann: 211118 AFT FY 22 Interim Result Investor Presentation
	AFP AFP Ann: 211118 AFT 1H FY22 Market Release
	AFP AFP Ann: FDA confirms earlier than expected PDUFA date for Maxigesic
	AFP AFP Ann: AFT appoints McPhersons as Singapore distributor
	AFP AFP Ann: US FDA accepts Maxigesic IV New Drug Application
	AFP AFP Ann: Maxigesic IV registered in the UK and Ireland
	AFP AFP Ann: half year interim results announcement 18 Nov 2021
	AFP AFP Ann: AFT further extends Maxigesic footprint strengthens EU
	AFP AFP Ann: Change of Capital notice
	AFP AFP Ann: ASM 2021 results
	AFP AFP Ann: ASM presentation
	AFP AFP Ann: ASM chairs address
	AFP AFP Ann: New clinical study Novaliq NovaTears Omega-3 eye drops
	AFP AFP Ann: Application for quotation of securities - AFP
	AFP AFP Ann: D&O Ongoing Disclosure - Louise Clayton
	AFP AFP Ann: Capital Change Notice - Issue of ordinary shares
	AFP AFP Ann: Maxigesic Oral Liquid gets first regulatory approval
	AFP AFP Ann: Maxigesic IV launches in Germany and Austria
	AFP AFP Ann: ASM 2021 Proxy form
	AFP AFP Ann: Notice of Annual Meeting of Shareholders 2021
	AFP AFP Ann: Application for quotation of securities - AFP
	AFP AFP Ann: Appendix 2A
	AFP AFP Ann: Capital Change Notice
	AFP AFP Ann: FY 2021 AFT Financial Presentation
	AFP AFP Ann: FY2021 Annual Report
	AFP AFP Ann: FY2021 Announcement App 2
	AFP AFP Ann: FY2021 Announcement
	AFP AFP Ann: Appendix 2A
	AFP AFP Ann: AFT extends Maxigesic IV license in South America

End of Day Prices

Date	Close	Volume	Change
14-Sep	$3.43	1,564	+0.01 (0.15%)
11-Sep	$3.43	65	-0.07 (1.86%)
10-Sep	$3.49	0	0.00 (0.00%)
09-Sep	$3.49	0	0.00 (0.00%)
08-Sep	$3.49	3,272	0.00 (0.00%)
07-Sep	$3.49	1,001	-0.16 (4.38%)
04-Sep	$3.65	0	0.00 (0.00%)
03-Sep	$3.65	316	-0.11 (2.93%)
02-Sep	$3.76	0	0.00 (0.00%)
01-Sep	$3.76	711	+0.11 (3.01%)
31-Aug	$3.65	3	0.00 (0.00%)
28-Aug	$3.65	2,396	+0.05 (1.39%)
27-Aug	$3.60	262	-0.08 (2.17%)
26-Aug	$3.68	1,784	-0.09 (2.39%)
24-Aug	$3.77	377	+0.02 (0.53%)
4 up, 5 down, and 6 flat days

AFT Pharmaceuticals Health Care
Pharmaceuticals

Short Interest

Followers

Prices

Announcements

End of Day Prices

AFT Pharmaceuticals Health Care Pharmaceuticals

Short Interest

Followers

Prices

Announcements

End of Day Prices

AFT Pharmaceuticals Health Care
Pharmaceuticals